»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
°â»ó ÀûÇ÷±¸Áõ Ä¡·á ½ÃÀåÀº 2024-2029³â 33¾ï 4,510¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 16.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ °â»ó ÀûÇ÷±¸Áõ Ä¡·á ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. °â»ó ÀûÇ÷±¸ ÁúȯÀÇ ³ôÀº À¯º´·ü, Á¤ºÎ ¹× ºñ¿µ¸® ´ÜüÀÇ Áö¿ø, ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó °³¼± µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³âºñ
14.4%
CAGR
16.2%
Áõ°¡¾×
33¾ï 4,510¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü »óȲ, ÁÖ¿ä ±â¾÷ ºÐ¼®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³â µ¿¾È °â»ó ÀûÇ÷±¸Áõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î ´ëÁõ¿ä¹ý¿¡¼ Ä¡·áÀû Á¢±Ù¹ýÀ¸·ÎÀÇ ÀüȯÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, Àü·«Àû ÆÄÆ®³Ê½Ê°ú Çù¾÷, ÀÎ½Ä °³¼± Ä·ÆäÀο¡ ´ëÇÑ ÁýÁßÀº ½ÃÀåÀÇ Å« ¼ö¿ä¸¦ âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤¿ë·ü¡¤±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå »óȲ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀå Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024³â
½ÃÀå Àü¸Á 2024-2029³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
°â»ó ÀûÇ÷±¸Áõ Ä¡·á ¼¼°è ½ÃÀå 2019-2023³â
Ä¡·á ºÐ¾ßº° ºÎ¹® ºÐ¼® 2019-2023³â
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼® 2019-2023³â
ÀûÀÀÁõº° ºÎ¹® ºÐ¼® 2019-2023³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023³â
Á¦6Àå Á¤¼º ºÐ¼®
¹Ì±¹ °ü¼¼ÀÇ ¿µÇ⠺м® : °â»ó ÀûÇ÷±¸Áõ Ä¡·á ¼¼°è ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô Âü¿©¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå »óȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : Ä¡À¯ ¿µ¿ªº°
½ÃÀå ºÎ¹®
ºñ±³ : Ä¡À¯ ¿µ¿ªº°
¼öÇ÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾à¹°¿ä¹ý : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
°ñ¼ö ÀÌ½Ä : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Ä¡À¯ ¿µ¿ªº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àü¹® Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿Ü·¡ ¼ö¼ú ¼¾ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ÀûÀÀÁõº°
½ÃÀå ºÎ¹®
ºñ±³ : ÀûÀÀÁõº°
°â»ó ÀûÇ÷±¸ ºóÇ÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ÀûÀÀÁõº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ºê¶óÁú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
AbbVie Inc.
Agios Inc.
bluebird bio Inc.
Bristol Myers Squibb Co.
CHIESI Farmaceutici SpA
CRISPR Therapeutics AG
Editas Medicine Inc.
Emmaus Medical Inc.
Intellia Therapeutics Inc.
Medunik USA
Novartis AG
Pfizer Inc.
Prolong Pharmaceuticals LLC
Sanofi SA
Vertex Pharmaceuticals Inc.
Á¦16Àå ºÎ·Ï
ksm
The sickle cell disease treatment market is forecasted to grow by USD 3,345.1 mn during 2024-2029, accelerating at a CAGR of 16.2% during the forecast period. The report on the sickle cell disease treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of sickle cell disease, government and nonprofit support, and improved healthcare infrastructure in emerging markets.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 14.4%
CAGR 16.2%
Incremental Value $3,345.1 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's sickle cell disease treatment market is segmented as below:
By Therapeutic Area
Blood transfusion
Pharmacotherapy
Bone marrow transplant
By End-user
Hospitals
Specialty clinics
Ambulatory surgical centers
By Indication
Sickle cell anemia
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the shift from symptom management to curative approaches as one of the prime reasons driving the sickle cell disease treatment market growth during the next few years. Also, strategic partnerships and collaborations and focus on awareness campaigns will lead to sizable demand in the market.
The report on the sickle cell disease treatment market covers the following areas:
Sickle Cell Disease Treatment Market sizing
Sickle Cell Disease Treatment Market forecast
Sickle Cell Disease Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sickle cell disease treatment market vendors that include AbbVie Inc., Agios Inc., AstraZeneca Plc, bluebird bio Inc., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, CRISPR Therapeutics AG, Editas Medicine Inc., Emmaus Medical Inc., F. Hoffmann La Roche Ltd., Intellia Therapeutics Inc., Medunik USA, Novartis AG, Pfizer Inc., Prolong Pharmaceuticals LLC, Sanofi SA, and Vertex Pharmaceuticals Inc.. Also, the sickle cell disease treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Indication
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Sickle Cell Disease Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Sickle Cell Disease Treatment Market 2019 - 2023 ($ million)
5.2 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Indication segment analysis 2019 - 2023
Historic Market Size - Indication Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact Analysis of U.S. Tariffs on Global Sickle Cell Disease Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Therapeutic Area
8.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
8.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
8.3 Blood transfusion - Market size and forecast 2024-2029
Chart on Blood transfusion - Market size and forecast 2024-2029 ($ million)
Data Table on Blood transfusion - Market size and forecast 2024-2029 ($ million)
Chart on Blood transfusion - Year-over-year growth 2024-2029 (%)
Data Table on Blood transfusion - Year-over-year growth 2024-2029 (%)
8.4 Pharmacotherapy - Market size and forecast 2024-2029
Chart on Pharmacotherapy - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmacotherapy - Market size and forecast 2024-2029 ($ million)
Chart on Pharmacotherapy - Year-over-year growth 2024-2029 (%)
Data Table on Pharmacotherapy - Year-over-year growth 2024-2029 (%)
8.5 Bone marrow transplant - Market size and forecast 2024-2029
Chart on Bone marrow transplant - Market size and forecast 2024-2029 ($ million)
Data Table on Bone marrow transplant - Market size and forecast 2024-2029 ($ million)
Chart on Bone marrow transplant - Year-over-year growth 2024-2029 (%)
Data Table on Bone marrow transplant - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
9.4 Specialty clinics - Market size and forecast 2024-2029
Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
9.5 Ambulatory surgical centers - Market size and forecast 2024-2029
Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ million)
Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Indication
10.1 Market segments
Chart on Indication - Market share 2024-2029 (%)
Data Table on Indication - Market share 2024-2029 (%)
10.2 Comparison by Indication
Chart on Comparison by Indication
Data Table on Comparison by Indication
10.3 Sickle cell anemia - Market size and forecast 2024-2029
Chart on Sickle cell anemia - Market size and forecast 2024-2029 ($ million)
Data Table on Sickle cell anemia - Market size and forecast 2024-2029 ($ million)
Chart on Sickle cell anemia - Year-over-year growth 2024-2029 (%)
Data Table on Sickle cell anemia - Year-over-year growth 2024-2029 (%)
10.4 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Indication
Market opportunity by Indication ($ million)
Data Table on Market opportunity by Indication ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Agios Inc.
Agios Inc. - Overview
Agios Inc. - Product / Service
Agios Inc. - Key offerings
SWOT
15.6 bluebird bio Inc.
bluebird bio Inc. - Overview
bluebird bio Inc. - Product / Service
bluebird bio Inc. - Key offerings
SWOT
15.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.8 CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA - Overview
CHIESI Farmaceutici SpA - Product / Service
CHIESI Farmaceutici SpA - Key offerings
SWOT
15.9 CRISPR Therapeutics AG
CRISPR Therapeutics AG - Overview
CRISPR Therapeutics AG - Product / Service
CRISPR Therapeutics AG - Key offerings
SWOT
15.10 Editas Medicine Inc.
Editas Medicine Inc. - Overview
Editas Medicine Inc. - Product / Service
Editas Medicine Inc. - Key offerings
SWOT
15.11 Emmaus Medical Inc.
Emmaus Medical Inc. - Overview
Emmaus Medical Inc. - Product / Service
Emmaus Medical Inc. - Key offerings
SWOT
15.12 Intellia Therapeutics Inc.
Intellia Therapeutics Inc. - Overview
Intellia Therapeutics Inc. - Product / Service
Intellia Therapeutics Inc. - Key offerings
SWOT
15.13 Medunik USA
Medunik USA - Overview
Medunik USA - Product / Service
Medunik USA - Key offerings
SWOT
15.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC - Overview
Prolong Pharmaceuticals LLC - Product / Service
Prolong Pharmaceuticals LLC - Key offerings
SWOT
15.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.18 Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc. - Overview
Vertex Pharmaceuticals Inc. - Product / Service
Vertex Pharmaceuticals Inc. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations